Literature DB >> 31385848

Recovery From Opioid Problems in the US Population: Prevalence, Pathways, and Psychological Well-Being.

Lauren A Hoffman1, Corrie Vilsaint, John F Kelly.   

Abstract

OBJECTIVES: Research has enhanced our understanding of opioid misuse prevalence and consequences, but few studies have examined recovery from opioid problems. Estimating national recovery prevalence and characterizing individuals who have resolved opioid problems can inform policy and clinical approaches to address opioid misuse.
METHODS: We conducted a cross-sectional investigation of a nationally-representative sample of US adults who reported opioid problem resolution (OPI). For reference, OPI was compared with an alcohol problem resolution group (ALC). Analyses estimated OPI/ALC prevalence, differences in treatment/recovery service use, and psychological well-being, within 2 recovery windows: <1 year (early recovery) and 1 to 5 years (mid-recovery) since OPI/ALC problem resolution.
RESULTS: Of those who reported alcohol or drug use problem resolution, weighted problem resolution prevalence was 5.3% for opioids (early recovery 1.2%, mid-recovery 2.2%) and 51.2% for alcohol (early recovery 7.0%, mid-recovery 11.5%). In mid-recovery, lifetime use of formal treatment, pharmacotherapy, recovery support services, mutual help, and current pharmacotherapy were more prevalent in OPI than ALC. Service utilization did not differ between early-recovery OPI and ALC. Common services used by OPI included inpatient treatment (37.8%) and state/local recovery organizations (24.4%) in mid-recovery; outpatient treatment (25.7%) and recovery community centers (27.2%) in early recovery; Narcotics Anonymous (40.2%-57.8%) and buprenorphine-naloxone (15.3%-26.7%) in both recovery cohorts. Regarding well-being, OPI reported higher self-esteem than ALC in early recovery, and lower self-esteem than ALC in mid-recovery.
CONCLUSIONS: An estimated 1.2 million American adults report resolving an opioid problem. Given the service use outcomes and longer-term problem resolution of mid-recovery OPI, early-recovery OPI may require encouragement to utilize additional or more intensive services to achieve longer-term recovery. OPI beyond recovery-year 1 may need enhanced support to address deficient self-esteem and promote well-being.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31385848      PMCID: PMC6995444          DOI: 10.1097/ADM.0000000000000561

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  6 in total

1.  One-Stop Shopping for Recovery: An Investigation of Participant Characteristics and Benefits Derived From U.S. Recovery Community Centers.

Authors:  John F Kelly; Robert L Stout; Leonard A Jason; Nilofar Fallah-Sohy; Lauren A Hoffman; Bettina B Hoeppner
Journal:  Alcohol Clin Exp Res       Date:  2020-02-03       Impact factor: 3.455

2.  Role of Peer Coaches in Digital Interventions for MOUD Initiation and Maintenance.

Authors:  Renee Garett; Sean D Young
Journal:  Community Ment Health J       Date:  2022-08-01

3.  Impact of 12 step mutual help groups on drug use disorder patients across six clinical trials.

Authors:  Keith Humphreys; Nicolas B Barreto; Sheila M Alessi; Kathleen M Carroll; Paul Crits-Christoph; Dennis M Donovan; John F Kelly; Richard S Schottenfeld; Christine Timko; Todd H Wagner
Journal:  Drug Alcohol Depend       Date:  2020-08-04       Impact factor: 4.492

4.  Recovery community centers: Characteristics of new attendees and longitudinal investigation of the predictors and effects of participation.

Authors:  John F Kelly; Nilofar Fallah-Sohy; Julie Cristello; Robert L Stout; Leonard A Jason; Bettina B Hoeppner
Journal:  J Subst Abuse Treat       Date:  2021-01-13

5.  Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees.

Authors:  Lauren A Hoffman; Corrie L Vilsaint; John F Kelly
Journal:  J Subst Abuse Treat       Date:  2021-05-08

6.  Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment.

Authors:  Jesse L Yedinak; William C Goedel; Kimberly Paull; Rebecca Lebeau; Maxwell S Krieger; Cheyenne Thompson; Ashley L Buchanan; Tom Coderre; Rebecca Boss; Josiah D Rich; Brandon D L Marshall
Journal:  PLoS Med       Date:  2019-11-19       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.